-
Full video: Bilawal makes minister to open bottle for him
samanews 2021/12/11 -
Omicron: South African doctors see milder sign than delta variant of Covid
Business Standard 2021/12/11 -
Congress rally to script downfall of BJP-led Union govt: Cong leader Pilot
Business Standard 2021/12/11 -
When did Antarctica become a continent?
Live Science 2021/12/11 -
I Left QAnon in 2019. But I’m Still Not Free.
Politico 2021/12/11 -
Soaring inflation could hamper Biden’s effort to narrow wealth, racial disparities
Politico 2021/12/11 -
The Good News for the GOP Is Only Temporary
Politico 2021/12/11 -
Malinowski supporters flood the zone, fearing he’ll be ‘sacrificed’ in redistricting
Politico 2021/12/11 -
Gov. Beshear: Death toll could be between 70 and 100 people after tornadoes touch down in Kentucky
WBIR 2021/12/11 -
And Just Like That cast filmed fake scene to throw off fans and paparazzi
INDEPENDENT 2021/12/11 -
Sisi: Egypt is keen to uphold the social and economic rights of citizens
EGYPT INDEPENDENT 2021/12/11 -
Pakistani Taliban kill police officer guarding polio jab team
Aljazeera 2021/12/11 -
Pep Ljinders could land Liverpool job after Jurgen Klopp in big blow to Steven Gerrard
Daily Star 2021/12/11 -
Tottenham fans want UEFA to give them 3-0 loss to crash out of Conference League
Daily Star 2021/12/11 -
Russia has no plans to attack Ukraine: Kremlin
Devdiscourse 2021/12/11 -
UPDATE 4-Many trapped after Amazon warehouse roof collapse near U.S. city of St. Louis
Devdiscourse 2021/12/11 -
Sunday rally will be decisive against "arrogant" Modi government: Congress
Devdiscourse 2021/12/11 -
Phase 3 Data Demonstrate TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
PR Newswire 2021/12/11 -
Daten der Phase III zeigen: TIBSOVO® (Ivosidenib-Tabletten) in Kombination mit Azacitidin verbessert signifikant das ereignisfreie Überleben und das Gesamtüberleben bei Patienten mit zuvor unbehandelter IDH1-mutierter akuter myeloischer Leu
PR Newswire 2021/12/11 -
Los datos en fase III muestran que TIBSOVO® (comprimidos de ivosidenib) en combinación con azacitidina mejora significativamente la supervivencia sin acontecimientos y la supervivencia general en pacientes con leucemia mieloide aguda con mu
PR Newswire 2021/12/11
Most Viewed News
MLBtraderumors Before 10 hours & 11 minute
Newsweek Before 19 hour & 7 minute
Parade Before 19 hour & 3 minute
inews Before 19 hour & 5 minute
Gizmodo Before 11 hour & 27 minute
Parade Before 21 hour & 24 minute
Parade Before 5 hours & 37 minute
Live Hacker Before 10 hours & 44 minute
Parade Before 10 hours
Parade Before 13 hour & 54 minute